LIVERSTAT first-line screening tool: MAFLD patients outperformed standard-of-care FIB-4 (training/validation) easlfibronostg on June 29, 2026 Category: Publications Tag: Identification, LiverSTAT, MAFLD, MASLD, Screening Post navigation Previous: Previous post: Recommended Clinical Care Pathway with FIB-4 underestimates the prevalence of Advanced Fibrosis, compared to sequential CCP with LIVERSTAT and LSM (NHANES)Next: Next post: Evaluation of LIVERFASt for staging fibrosis in MASLD patients in NIDDK studies using liver biopsy
